Brightstar Therapeutics Secures Series A Financing to Propel Groundbreaking Treatment for Corneal Diseases; Appoints Chief Medical Officer and Chief Scientific Officer to Lead
Brightstar Therapeutics Logo
LEXINGTON, Ky., April 18, 2023 (Newswire.com)
–
Brightstar Therapeutics, a biotechnology company focused on providing inno…
